Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: Faecal immunochemical test vs. guaiac-based faecal occult blood test

Alimentary Pharmacology and Therapeutics

Volumn 31, Issue 3, 2010, Pages 432-439

  Oort, F A ^a   Terhaar Sive Droste, J S ^a   Van Der Hulst, R W M ^b   Van Heukelem, H A ^c   Loffeld, R J L F ^d   Wesdorp, I C E ^e   Van Wanrooij, R L J ^a   De Baaij, L ^a   Mutsaers, E R ^a   Van Der Reijt, S ^a   Coupe, V M H ^a   Berkhof, J ^a   Bouman, A A ^a   Meijer, G A ^a   Mulder, C J J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b Infection and Immunology   (Netherlands)

^c SLOTERVAART HOSPITAL   (Netherlands)

^d ZAANS MEDICAL CENTER   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; GUAIAC; HUMANS; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 73549102676     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04184.x     Document Type: Article

References (34)

1. Greegor DH. A progress report. Detection of colorectal cancer using guaiac slides. CA Cancer J Clin 1972 22 : 360 363.
2. Allison JE. Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better FIT. Gastroenterology 2005 129 : 745 748.
3. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000 343 : 1603 1607.
4. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996 348 : 1467 1471.
5. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993 328 : 1365 1371.
6. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996 348 : 1472 1477.
7. Allison JE. Review article: faecal occult blood testing for colorectal cancer. Aliment Pharmacol Ther 1998 12 : 1 10.
8. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening Population. Gastroenterology 2008 135 : 82 90.
9. Young GP, Sinatra MA, St John DJ. Influence of delay in stool sampling on fecal occult blood test sensitivity. Clin Chem 1996 42 : 1107 1108.
10. Young GP, Cole S. New stool screening tests for colorectal cancer. Digestion 2007 76 : 26 33.
11. Kronborg O, Regula J. Population screening for colorectal cancer: advantages and drawbacks. Dig Dis 2007 25 : 270 273. (Pubitemid 350194182)
12. Launoy GD, Bertrand HJ, Berchi C, et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 2005 115 : 493 496. (Pubitemid 40663756)
13. Hepler OE, Wong P, Pihl HD. Comparison of tests for occult blood in feces. Am J Clin Pathol 1953 23 : 1263 1272.
14. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007 99 : 1462 1470.
15. Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 2008 44 : 2254 2258.
16. Bossuyt PM, Irwig L, Craig J, Glasziou P. Comparative accuracy: assessing new tests against existing diagnostic pathways. Br Med J 2006 332 : 1089 1092.
17. Guittet L, Bouvier V, Mariotte N, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007 56 : 210 214.
18. Ransohoff DF. What is the role of iFOBT in screening for colorectal cancer? Gut 2007 56 : 1343 1344.
19. Young GP, Cole SR. Which fecal occult blood test is best to screen for colorectal cancer? Nat Clin Pract Gastroenterol Hepatol 2009 6 : 140 141.
20. Pignone M, Campbell MK, Carr C, Phillips C. Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 2001 4 : 150 156.
21. Rozen P, Waked A, Vilkin A, Levi Z, Niv Y. Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood. Med Sci Monit 2006 12 : MT27 32.
22. Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 2006 56 : 160 167. (Pubitemid 43847926)
23. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993 328 : 901 906.
24. Greene Fea. AJCC (American Joint Committee on Cancer) Cancer Staging Manual. Springer-Verlag, New York City, NY, USA, 2002 113.
25. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008 149 : 441 450, W81.
26. Grazzini G, Ciatto S, Cislaghi C, et al. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence. J Med Screen 2008 15 : 175 181.
27. Altman D. Practical Statistics for Medical Research. Chapman & Hall/CRC, London, 1991 409 413.
28. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008 149 : 627 637.
29. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007 146 : 244 255.
30. Selinger RR, Norman S, Dominitz JA. Failure of health care professionals to interpret fecal occult blood tests accurately. Am J Med 2003 114 : 64 7.
31. Denis BJ, Ruetsch M, Strentz P, et al. Short-term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 2007 56 : 1579 1584.
32. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008 122 : 1357 1367.
33. Wong BC, Wong WM, Cheung KL, et al. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 2003 18 : 941 946.
34. Levi Z, Hazazi R, Rozen P, Vilkin A, Waked A, Niv Y. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test. Aliment Pharmacol Ther 2006 23 : 1359 1364.